Education
About Us
Working with TipRanks
Follow Us
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
SONVY Stock Chart & Stats
$52.91
-$0.29(-0.44%)
At close: 4:00 PM EST
$52.91
-$0.29(-0.44%)
Day’s Range― - ―
52-Week Range$48.08 - $67.90
Previous CloseN/A
Volume1.17K
Average Volume (3M)3.58K
Market Cap
$14.91B
Enterprise Value$13.56B
Total Cash (Recent Filing)$511.00M
Total Debt (Recent Filing)$227.70M
Price to Earnings (P/E)25.8
Beta0.69
Next Earnings
May 19, 2026EPS Estimate
1.41Next Dividend Ex-DateN/A
Dividend Yield2.08%
Share Statistics
EPS (TTM)0.90
Shares Outstanding298,134,030
10 Day Avg. Volume2,397
30 Day Avg. Volume3,581
Financial Highlights & Ratios
PEG Ratio-2.90
Price to Book (P/B)5.77
Price to Sales (P/S)3.98
P/FCF Ratio23.42
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue3.56
Enterprise Value/Gross Profit5.02
Enterprise Value/Ebitda16.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.38
Revenue Forecast (FY)$4.89B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent operating cash conversion and rising free cash flow provide durable funding for R&D, product launches and reinvestment. Strong cash generation underpins financial flexibility to support innovation, service expansion and modest debt reduction over the medium term.
High Margins And ProfitabilitySustained high gross and EBIT margins reflect differentiated products, service revenues and disciplined cost control. These structural margins support reinvestment in technology and aftercare services, making earnings more resilient to cyclical swings in unit volumes over several quarters.
Market Share Gains From Product InnovationOutperforming market growth in core Hearing Instruments and Audiological Care, driven by recent platform launches, indicates durable competitive advantage. Successful new products and lead-generation investments support continued share gains and longer-term revenue momentum.
Bears Say
Gross Margin Pressure From Regionalization CostsMargin contraction tied to regionalizing manufacturing and logistics may persist while new footprints scale. If cost saves take longer to materialize, structural margin recovery could be delayed and offset part of operating leverage from higher sales.
Weakness In Smaller Business SegmentsUnderperformance in Consumer Hearing and Cochlear Implants reduces diversification of growth streams. Structural procurement and upgrade-cycle issues in key markets like China can depress volumes and slow overall revenue mix improvement for multiple quarters.
Material Currency HeadwindsSignificant FX translation impacts create recurring volatility in reported top-line and margin metrics given a Swiss reporting currency and global revenue footprint. Persistent currency strength can structurally depress reported growth absent hedging or pricing adjustments.
Sonova Holding AG News
SONVY FAQ
What was Sonova Holding AG Unsponsored ADR’s price range in the past 12 months?
Sonova Holding AG Unsponsored ADR lowest stock price was $48.08 and its highest was $67.90 in the past 12 months.
What is Sonova Holding AG Unsponsored ADR’s market cap?
Sonova Holding AG Unsponsored ADR’s market cap is $14.91B.
When is Sonova Holding AG Unsponsored ADR’s upcoming earnings report date?
Sonova Holding AG Unsponsored ADR’s upcoming earnings report date is May 19, 2026 which is in 77 days.
How were Sonova Holding AG Unsponsored ADR’s earnings last quarter?
Sonova Holding AG Unsponsored ADR released its earnings results on Nov 14, 2025. The company reported $0.897 earnings per share for the quarter, missing the consensus estimate of $0.982 by -$0.085.
Is Sonova Holding AG Unsponsored ADR overvalued?
According to Wall Street analysts Sonova Holding AG Unsponsored ADR’s price is currently Overvalued.
Does Sonova Holding AG Unsponsored ADR pay dividends?
Sonova Holding AG Unsponsored ADR pays a Annually dividend of $1.077 which represents an annual dividend yield of 2.08%. See more information on Sonova Holding AG Unsponsored ADR dividends here
What is Sonova Holding AG Unsponsored ADR’s EPS estimate?
Sonova Holding AG Unsponsored ADR’s EPS estimate is 1.41.
How many shares outstanding does Sonova Holding AG Unsponsored ADR have?
Sonova Holding AG Unsponsored ADR has 298,134,030 shares outstanding.
What happened to Sonova Holding AG Unsponsored ADR’s price movement after its last earnings report?
Sonova Holding AG Unsponsored ADR reported an EPS of $0.897 in its last earnings report, missing expectations of $0.982. Following the earnings report the stock price went down -7.172%.
Which hedge fund is a major shareholder of Sonova Holding AG Unsponsored ADR?
Currently, no hedge funds are holding shares in SONVY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonova Holding AG Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.09%
12-Months-Change
Fundamentals
Return on Equity
21.18%
Trailing 12-Months
Asset Growth
4.13%
Trailing 12-Months
Company Description
Sonova Holding AG Unsponsored ADR
Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
SONVY Company Deck
SONVY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a strong performance in the larger business segments with significant market share gains, supported by successful product launches and innovation. However, challenges in smaller segments, currency headwinds, and a decline in gross margins were notable concerns. The outlook remains positive with growth expectations, but market volatility and currency impacts pose challenges.View all SONVY earnings summariesTechnical Analysis
Insulet
―
Koninklijke Philips
―
Smith & Nephew Snats
―
Steris
―
Zimmer Biomet Holdings
―
Ownership Overview
―
Insiders
1.02% Mutual Funds
<0.01% Other Institutional Investors
98.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---